| Click for the Finfacts Ireland Portal Homepage |

Finfacts Business News Centre

News Main Page 
 Asia-Pacific Business Week


How to use our RSS feed

Web Finfacts


Finfacts is Ireland's leading business information site and you are in its business news section.

We provide access to live business television and business related videos from: Bloomberg TV; The Wall Street Journal; CNBC and the Financial Times. Click image:


Finfacts Homepage

Global News

Bloomberg News

CNN Money

Cnet Tech News


Irish Independent

Irish Times

Irish Examiner

New York Times

Financial Times

Technology News





News : European Last Updated: Dec 19th, 2007 - 13:17:15

One in two Europeans believe biotechnology will improve quality of life; Majority oppose GM food
By Finfacts Team
Jun 19, 2006, 11:12

Email this article
 Printer friendly page

52% of those polled in the latest Eurobarometer survey on biotechnology, published today, indicated a belief that biotechnology will improve their quality of life. The Eurobarometer “Europeans and biotechnology in 2005” shows that most Europeans are in favour of medical (red) applications of biotechnology when there are clear benefits for human health; and industrial (white)applications, but they are still mostly sceptical about agricultural (green) biotech, and will continue to be so unless new crops and products are seen to have consumer benefits.

Table 3: Outright support and risk tolerant support for GM food across EU25

Confidence has increased in the European Union's regulation of biotechnology but there is no evidence that this has influenced the public's reported purchasing intentions, especially for GM foods. Overall, optimism about biotechnology's contribution to improving society has grown significantly since 1999. There is also support for research using stem cells, provided this is tightly regulated. This survey is the latest in a series of regular surveys on attitudes to biotechnology undertaken since 1991. The survey will be presented at a workshop on 22 June 2006 in Brussels.

The survey examines issues such as:

  • Optimism about the contribution of technology, including biotechnology, to our way of life. Here, the survey shows that optimism about biotechnology has increased since 1999, after a period of decline (52% say it will improve their life)
  • The development of nanotechnology, pharmacogenetics (analysing a person’s genetic code in order to create drugs which are tailored to him/her and are therefore more effective) and gene therapy, all three of which are generally perceived as useful to society and morally acceptable.
  • GM food, where a majority of Europeans (58%) think it should not be encouraged,
  • Industrial (white) technologies, such as bio-fuels, bio-plastics (plastics manufactured from crop plants) and biopharming (the use of genetically modified plants in the production of medicines and pharmaceutical products) for pharmaceuticals, which are widely supported.
  • Stem cell research, where there is considerable support across Europe, if tightly regulated. There is approval for use of both stem cells derived from umbilical cords (65%) and embryonic stem cells (59%), with 26% of people saying they do not approve of embryonic stem cell research at all or only under very special circumstances.

  • Use of personal genetic data, with 58% of participants indicating they would allow their genetic data to be banked for research purposes, though there are differing levels of support for genetic data banks across the EU.
  • Trust in actors involved in biotechnology, which shows growing levels of trust in university and industry scientists (73% and 64%). The EU is seen as more trustworthy than national governments on issues of regulating biotechnology (74% compared with 68%).
  • Comparison of attitudes with US and Canada, dispelling claims that European public opinion is more technology-adverse than its transatlantic partners.

Close analysis of the data shows that it is inaccurate to ascribe certain attitudes to biotechnology by age group, or gender.

This survey is the latest in a series of such Eurobarometers on biotechnology conducted in 1991, 1993, 1996, 1999, 2002 and 2005. The sixth Eurobarometer on Biotechnology 2005 is based on a representative sample of 25 000 respondents, approximately 1 000 in each EU Member State.

Download report.

© Copyright 2007 by Finfacts.com

Top of Page

Latest Headlines
German ZEW Indicator of Economic Sentiment fell in January to a to 15-Year low indicating plunge in investor confidence
UK Annual Consumer Price Inflation held steady in December at 2.1%
Total cost of employment in Ireland at €38,541in 2007 - 16th of 24 EU countries; New EU member states have lowest labour costs
European Union countries fighting over share-out for cutting greenhouse gas emissions; Environment Commissioner now says some biofuels do more harm than good
UK factory gate/wholesale price annual inflation rose to 5% in December - the highest since 1991
Eurozone industrial production fell 0.5% in November
Manchester United almost doubled profit in 2007; Premier League clubs’ revenues to increase significantly in 2007/08 to over £1.76bn
Trichet says ECB is in position of "total alertness" to act in response to price/wage setting linked to the current high Eurozone headline inflation rate
European Central Bank keeps its its benchmark interest rate on hold at 4.00%; Trichet to warn of inflation risks at press conference
Bank of England keeps benchmark interest rate unchanged at 5.50%
European Central Bank expected to keep benchmark interest rate on hold at 4%; Bank of England base rate cut likely
Eurozone Economic Outlook: GDP growth to slow to annual rate of 2.1% in Q2 2008; If negative shocks were to fade economic slowdown may be only transitory
European Commission analysis looks at the role of India in world agriculture
Eurozone GDP revised up to 0.8% in Q3 2007 - up 2.7% in year to September
German exports and retail sales fell in November 2007
UK Consumer Confidence fell in December; Marks & Spencer reports first same-store sales fall in 2 1/2 years on reduced Christmas spending
Eurozone retail sales volume fell 0.5% in November 2007 - down 1.4% on annual basis but up 0.9% in EU27
UK Retail Sales December 2007: A far from Merry Christmas in the High Street
UK sales of commercial property plunged in Q4 2007 because of credit crunch; Market set for biggest annual losses in more than 25 years
Eurozone Business Climate Indicator and Economic Sentiment Indicator weakened in December 2007